Oragenics, Inc.
OGEN · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $73 | $380 | $380 | $1,511 |
| - Cash | $1 | $3 | $11 | $27 |
| + Debt | $0 | $0 | $1 | $1 |
| Enterprise Value | $73 | $377 | $369 | $1,484 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$11 | -$21 | -$14 | -$16 |
| % Margin | – | – | – | – |
| Net Income | -$11 | -$21 | -$14 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.6 | -9.18 | -7.11 | -8.09 |
| % Growth | 82.6% | -29.1% | 12.1% | – |
| Operating Cash Flow | -$9 | -$7 | -$15 | -$13 |
| Capital Expenditures | $0 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$9 | -$8 | -$15 | -$14 |